In-vivo or in-vitro stone attenuation: what is more valuable for the prediction of renal stone composition in non-contrast-enhanced abdominal computed tomography?
Aktuelle Urologie · 01.02.2023 · 54 (01) · 30-36
DOI: 10.1055/a-1971-6759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aktuelle Urologie, erschienen am 01.02.2023. Verfasst von Yavuz Ilki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cerrahpasa Faculty of Medicine, Department of Urology, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Calcium, Kidney Calculi. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
To compare the efficacy of in-vivo and in-vitro stone attenuation in the prediction of stone composition using non-contrast-enhanced abdominal computed tomography (NCCT).
Methods
This study included a total of 104 patients with renal stones who received percutaneous nephrolithotomy treatment for renal stones between December 2016 and December 2019 and underwent NCCT before the procedure. Preoperative (in-vivo) and postoperative (in-vitro) kidney stone attenuations were compared using the NCCT images of the patients. Renal stone fragments were analysed with the infrared spectrophotometer method.
Results
The mean age of the 104 patients was 49.5 (interquartile range: 37–61) years. According to the receiver operating characteristics analysis, the cut-off values for the prediction of uric acid stones were determined to be 556 HU for the in-vivo and 774 HU for the in-vitro attenuation measurement. Sensitivity and specificity were 100% and 96.6%, respectively, for the in-vivo and 90.9 and 91%, respectively, for the in-vitro images. The cut-off values for the prediction of calcium stones were determined to be 824 HU and 1065 HU for the in-vivo and in-vitro attenuation measurements, respectively. Sensitivity and specificity were 97.3 and 96% for the in-vivo and 96 and 96% for the in-vitro images.
Conclusions
In-vivo stone attenuation measurement in NCCT was slightly superior to in-vitro measurement due to the reduction in the composition and size of the stone. Our findings show that NCCT in-vivo stone attenuation might differentiate uric acid and calcium stones from the other stone types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cerrahpasa Faculty of Medicine, Department of Urology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Cerrahpasa Faculty of Medicine, Department of Radiology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
ORCID-Profile: Emre Bulbul, Mehmet Hamza Gultekin
Zitieren
APA
Ilki, Y., Bulbul, E., Gultekin, M. H., Erozenci, A., Tutar, O., Citgez, S., & Onal, B. (2023). In-vivo or in-vitro stone attenuation: what is more valuable for the prediction of renal stone composition in non-contrast-enhanced abdominal computed tomography?. Aktuelle Urologie, 54(01), 30-36. https://doi.org/10.1055/a-1971-6759
Vancouver
Ilki Y, Bulbul E, Gultekin MH, Erozenci A, Tutar O, Citgez S, et al. In-vivo or in-vitro stone attenuation: what is more valuable for the prediction of renal stone composition in non-contrast-enhanced abdominal computed tomography?. Aktuelle Urologie. 2023;54(01):30-36. doi:10.1055/a-1971-6759
BibTeX
@article{Ilki2023,
author = {Ilki, Yavuz and Bulbul, Emre and Gultekin, Mehmet Hamza and Erozenci, Ahmet and Tutar, Onur and Citgez, Sinharib and Onal, Bulent},
title = {In-vivo or in-vitro stone attenuation: what is more valuable for the prediction of renal stone composition in non-contrast-enhanced abdominal computed tomography?},
journal = {Aktuelle Urologie},
year = {2023},
volume = {54},
number = {01},
pages = {30--36},
doi = {10.1055/a-1971-6759}
}
EUVIMED